Asked by: Wera Hobhouse (Liberal Democrat - Bath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help (a) increase survival rates from out-of-hospital cardiac arrests and (b) increase the availability of defibrillators in Bath.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
In order to increase survival rates from out-of-hospital cardiac arrest, NHS England has worked in partnership with St John’s Ambulance and others to increase access to cardiopulmonary resuscitation (CPR) training. Local ambulance trusts, charities including St John’s Ambulance, the British Heart Foundation, and private providers deliver CPR training and the use of defibrillators both in the community and in schools, under the Restart a Heart programme.
The Government’s position is that local communities are best placed to make decisions about procuring, locating and maintaining automated external defibrillators (AEDs). Over 110,000 defibrillators are registered in the United Kingdom on The Circuit, the independent AED database. Over 30,000 of these have been added in the past two years, many as a result of local community led action.
Asked by: Lord Bishop of Southwark (Bishops - Bishops)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what representations they have made to the government of Israel about the repair of graves in the Gaza war cemetery in al-Tuffah.
Answered by Baroness Chapman of Darlington - Minister of State (Development)
I refer the Hon Member to the answer provided by the Minister for the Middle East and North Africa on 13 February in response to Question 111058, which - for ease of reference - is reproduced below:
The Gaza War Cemetery in al-Tuffah holds the remains of more than 3,000 men who gave their lives in the First and Second World Wars, the majority from the United Kingdom, but many also from Australia, Canada, India, New Zealand, Poland, South Africa and other countries. As I said in the General Debate on 5 February, that includes Private William Jordan and Private Wilfrid Ogden, from my own constituency, who died during the Battles for Gaza in 1917.
There is justifiable distress in our country and elsewhere at the reports that the cemetery has been damaged by Israeli bulldozers, and we also deplore the reports that the cemetery has been used for Hamas military operations. Brave servicemen laid to rest overseas should never have had their graves defiled in this way. Alongside our international partners, we are raising our concerns about this with the Israeli authorities, and we will work with the Commonwealth War Graves Commission to ensure that - when the circumstances allow - they are able to go to Gaza, assess what damage has been done, and do what is necessary to repair that damage.
Asked by: Neil Duncan-Jordan (Labour - Poole)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he will increase the level of funding for import of medication from abroad to treat Acute Myeloid Leukaemia.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
It is important that patients with acute myeloid leukaemia can access safe and effective treatments when they need them. The Government’s priority is to maintain the continuity of supply of all medicines, including those sourced from abroad, and to take action with suppliers, National Health Service organisations, and regulators where supply issues arise.
Where there are no licensed available medicines in the United Kingdom, companies may manufacture or import unlicensed medicines. The Medicines and Healthcare products Regulatory Agency operates established routes that can enable clinicians and pharmacists to obtain unlicensed medicines for individual patients. Funding for these medicines is not set nationally. Instead, decisions on commissioning, procurement, and reimbursement for unlicensed medicines are made locally by NHS commissioners, who are best placed to determine how resources are allocated to meet the needs of their populations.
Asked by: Ayoub Khan (Independent - Birmingham Perry Barr)
Question to the Foreign, Commonwealth & Development Office:
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent discussions she has had with (a) her Israeli counterpart, (b) the Commonwealth War Graves Commission and (c) the Royal British Legion on the bulldozing of parts of The Gaza War Cemetery in al-Tuffah.
Answered by Hamish Falconer - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)
The Gaza War Cemetery in al-Tuffah holds the remains of more than 3,000 men who gave their lives in the First and Second World Wars, the majority from the United Kingdom, but many also from Australia, Canada, India, New Zealand, Poland, South Africa and other countries. As I said in the General Debate on 5 February, that includes Private William Jordan and Private Wilfrid Ogden, from my own constituency, who died during the Battles for Gaza in 1917.
There is justifiable distress in our country and elsewhere at the reports that the cemetery has been damaged by Israeli bulldozers, and we also deplore the reports that the cemetery has been used for Hamas military operations. Brave servicemen laid to rest overseas should never have had their graves defiled in this way. Alongside our international partners, we are raising our concerns about this with the Israeli authorities, and we will work with the Commonwealth War Graves Commission to ensure that - when the circumstances allow - they are able to go to Gaza, assess what damage has been done, and do what is necessary to repair that damage.
Asked by: Daniel Francis (Labour - Bexleyheath and Crayford)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what discussions he has with the Secretary of State for Business and Trade on the number of wheelchair accessible vehicles that are purchased through the Motability Scheme are produced in the United Kingdom.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
The Secretary of State regularly meets with colleagues across government to discuss a range of issues.
Motability Operations, an independent commercial company which delivers the Motability Scheme, will continue to prioritise customer needs, ensuring vehicles remain affordable and that support for wheelchair accessible vehicles and specialist adaptations remain at the heart of the Scheme.
Motability Operations has announced plans to support the government’s Modern Industrial Strategy. The number of British-made vehicles purchased by the Scheme will reach 25% by 2030, with an ambition of 50% of vehicles registered on the Scheme being made in the UK by 2035.
Asked by: Lord Roberts of Llandudno (Liberal Democrat - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they have taken to prepare for another global pandemic.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Ensuring the United Kingdom is prepared for a future pandemic is a top priority for the Government, and we are embedding lessons from the COVID-19 pandemic in our approach to pandemic preparedness. We aim to have flexible, adaptable, and scalable capabilities that can respond to any infectious disease or other threat, rather than relying on plans for specific threats.
The Government is committed to learning the lessons from the UK COVID-19 Inquiry to protect and prepare us for the future. On 16 January 2025, the Government published its response to the inquiry’s module one report on resilience and preparedness. A copy of the response is attached. The Department has committed, as part of this response, to publishing a new pandemic preparedness strategy that will show how we are embedding our new approach to pandemic preparedness.
In the 2024 Autumn budget, my Rt. Hon. Friend, the Chancellor of the Exchequer, announced that £460 million of investment has been allocated to strengthen the UK’s pandemic preparedness and health protection, including replenishing personal protective equipment, vaccine, and medicines stockpiles.
In autumn 2025, the Department and the UK Health Security Agency conducted Exercise Pegasus, a national exercise on the UK’s preparedness for a pandemic. It tested our ability to respond to a pandemic, involving all regions and nations of the UK and thousands of participants. The exercise has provided valuable experience which is being used to inform our strategy and planning. The Government has committed to communicating the findings through the post-exercise report this winter.
An established clinical countermeasures programme is a core component of our pandemic preparedness and set of response capabilities. These countermeasures include personal protective equipment and hygiene consumables, as well as vaccines and therapeutics, such as influenza antivirals and antibiotics.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government which national body has formal responsibility for monitoring outcomes for placenta accreta spectrum, including missed antenatal diagnoses and maternal morbidity.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
There are currently no plans to introduce mandatory national reporting of placenta accreta spectrum cases and outcomes. Neither Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) nor the National Maternity and Perinatal Audit record placenta accreta routinely in regular surveillance. However, MBRRACE-UK captures this data as part of their confidential enquiries relating to haemorrhage.
In 2020, NHS England commissioned placenta accreta networks in the United Kingdom which support local and regional screening, shared protocols, and co-ordinated referral pathways to specialist pregnancy accreta centres. Placenta accreta centres consist of highly experienced multidisciplinary teams with the expertise to manage this condition and improve the safety outcomes for women and babies.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they plan to introduce mandatory national reporting of placenta accreta spectrum cases and outcomes; and if so, over what timetable.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
There are currently no plans to introduce mandatory national reporting of placenta accreta spectrum cases and outcomes. Neither Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) nor the National Maternity and Perinatal Audit record placenta accreta routinely in regular surveillance. However, MBRRACE-UK captures this data as part of their confidential enquiries relating to haemorrhage.
In 2020, NHS England commissioned placenta accreta networks in the United Kingdom which support local and regional screening, shared protocols, and co-ordinated referral pathways to specialist pregnancy accreta centres. Placenta accreta centres consist of highly experienced multidisciplinary teams with the expertise to manage this condition and improve the safety outcomes for women and babies.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they plan to discuss the publication of data on maternal deaths and severe maternal morbidity specifically attributable to placenta accreta spectrum with Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
In 2020, NHS England commissioned placenta accreta networks in the United Kingdom which support local and regional screening, shared protocols, and co-ordinated referral pathways to specialist pregnancy accreta centres. These centres consist of highly experienced multidisciplinary teams with the expertise to manage this condition and improve the safety outcomes for women and babies.
At present, placenta accreta spectrum is not included as an indicator in NHS England maternity safety improvement programmes and dashboards. There are no plans to add this as an indicator in the future.
There are no plans to introduce mandatory national reporting of placenta accreta spectrum cases and outcomes. Neither Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) nor the National Maternity and Perinatal Audit record placenta accreta spectrum routinely in regular surveillance. However, MBRRACE-UK captures this data as part of the haemorrhage confidential enquiries. There are currently no plans to discuss the publication of this data.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether there is a national audit mechanism to review cases of placenta accreta spectrum that were not diagnosed antenatally and resulted in emergency hysterectomy, major haemorrhage or fatality.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
In 2020, NHS England commissioned placenta accreta networks in the United Kingdom which support local and regional screening, shared protocols, and co-ordinated referral pathways to specialist pregnancy accreta centres. These centres consist of highly experienced multidisciplinary teams with the expertise to manage this condition and improve the safety outcomes for women and babies.
At present, placenta accreta spectrum is not included as an indicator in NHS England maternity safety improvement programmes and dashboards. There are no plans to add this as an indicator in the future.
There are no plans to introduce mandatory national reporting of placenta accreta spectrum cases and outcomes. Neither Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) nor the National Maternity and Perinatal Audit record placenta accreta spectrum routinely in regular surveillance. However, MBRRACE-UK captures this data as part of the haemorrhage confidential enquiries. There are currently no plans to discuss the publication of this data.